(752f) Metabolic Engineering for Terpenoids Overproduction and Discovery | AIChE

Other Sites & Tools

Technical Groups

(752f) Metabolic Engineering for Terpenoids Overproduction and Discovery

Authors 

Liu, T. - Presenter, Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, and Wuhan University School of Pharmaceutical Sciences
Bian, G., Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, and Wuhan University School of Pharmaceutical Sciences
Zhu, F., Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, and Wuhan University School of Pharmaceutical Sciences
Ma, T., Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, and Wuhan University School of Pharmaceutical Sciences
Deng, Z., Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, and Wuhan University School of Pharmaceutical Sciences
Yuan, Y., Wuhan university
Hou, A., Wuhan university
Han, Y.
Cheng, S., Wuhan university
Terpenoids comprise the largest family of natural products with wide applications, and many of them have been engineered for commercial use. Our strategy for engineering terpenoids is based on the instruction of our in vitro reconstitution assay of mevalonate (MVA) pathway. The information from this system guided us to establish an efficient precursor-producing platform for terpenoids. Base on this well optimized platform, a high titer of farnesene was obtained in a short time with little mutant constructed[1]. Subsequently, we directly extend the application of this strategy and platform to realize a high titer production of lycopene[2], astaxanthin[3] and taxadiene[4] production in E. coli, S. cerevisiae and filamentous fungi quickly and efficiently.

Besides the production of terpenoids with important industrial applications, efficient heterologous terpenoids overproduction platforms also provide the perfect solution for us to activate the silent genes, gene clusters. Or resolve the problem that the production of target compounds is too low to be characterized, which may frequently encounter for natural product discovery. With the help of well-established terpenoids overproduction platforms in E. coli[5] and S. cerevisiae, we have characterized a large number of sesquiterpene, diterpene and sesterterpene synthase, which were usually silent or with low expression level in filamentous fungi. Some new terpene skeletons and new compounds that were usually difficult to obtain were discovered by this strategy. It's reasonable for us to believe that the our technical platform and strategy can promote the progress of natural products discovery greatly.

References:

1. Zhu F, Zhong X, Hu M, et al. (2014). Biotechnol Bioeng, 111, 1396-1405.

2. Zhu F, Lu L, Fu S, et al. (2015). Process Biochem, 50, 341-346.

3. Ma T, Zhou Y, Li X, et al. (2015). Biotechnol J, 11, 228-237.

4. Bian G, Yuan Y, Tao H, et al. (2017). Biotechnol J, doi: 10.1002/biot.201600697.

5. Bian G, Han Y, Hou A, et al. (2017). BioRxiv, http://biorxiv.org/content/early/2017/02/25/105247.

Topics 

Metabolic Engineering

More Conference Links